ACS Clinical Research Program rss

Figures 1A, 1B, 1C, 1D

Colorectal cancer metastatic to the liver: Making the unresectable resectable(Comments Off)

November 1, 2014

Advances in the treatment of metastatic colorectal cancer have led to greatly improved survival rates, especially for patients with liver-only disease. These new approaches have increased the role of surgeons in the management of these patients.

alliance logo CMYK

QOL concerns in surgical patients: Assessment and intervention

Deficits in perioperative quality of life and rehabilitation programs are described in this article, as are practical interventions for integrating the patient’s perspective into care management.

Treating metastatic prostate cancer now and in the future

The past decade has seen a paradigm shift in the treatment of men with advanced prostate cancer, according to the authors of this month column, a result of improved understanding of disease biology, investment in basic research and identification of rational therapeutic targets, collaboration with industry, and design and completion of well-designed clinical trials.

alliance logo CMYK

NCDB and ACS-CRP: Working together to develop risk-stratified strategies for surveillance

The Patient-Centered Outcomes Research Institute has awarded three research funding contracts to the ACS Cancer Research Program of the Alliance for Clinical Trials in Oncology with the goal of developing a more patient-centered and individualized approach to post-treatment surveillance of colorectal, breast, and lung cancers.

Dr. Morton

SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy

The ACS Oncology Group Z1071 trial and sentinel lymph node surgery in clinically node-positive patients receiving neoadjuvant chemotherapy are examined in this month’s column.


More in this category

« Older Posts   

Contact

Bulletin of the American College of Surgeons
633 N. Saint Clair St.
Chicago, IL 60611